His primary areas of investigation include Internal medicine, Cardiology, Surgery, Myocardial infarction and Stent. In his research on the topic of Cardiology, Odds ratio is strongly related with Confidence interval. Ron T. van Domburg works mostly in the field of Surgery, limiting it down to topics relating to Cohort and, in certain cases, Paclitaxel and Electrocardiography.
His Myocardial infarction research is multidisciplinary, incorporating perspectives in Stroke, Prospective cohort study and Chest pain. In his study, Cardiogenic shock is strongly linked to Percutaneous, which falls under the umbrella field of Stent. Ron T. van Domburg has included themes like Conventional PCI and Acute coronary syndrome in his Percutaneous coronary intervention study.
Ron T. van Domburg spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Surgery and Coronary artery disease. His work in the fields of Percutaneous coronary intervention, Stent, Hazard ratio and Confidence interval overlaps with other areas such as In patient. He interconnects Cumulative incidence and Sirolimus in the investigation of issues within Stent.
Cardiology is frequently linked to Radiology in his study. Ron T. van Domburg combines subjects such as Diabetes mellitus and Mortality rate with his study of Myocardial infarction. The concepts of his Surgery study are interwoven with issues in Angioplasty and Incidence.
Ron T. van Domburg mostly deals with Internal medicine, Cardiology, Percutaneous coronary intervention, Coronary artery disease and Physical therapy. Ron T. van Domburg usually deals with Internal medicine and limits it to topics linked to Surgery and Cohort. Ron T. van Domburg has researched Percutaneous coronary intervention in several fields, including Proportional hazards model, Stent, Conventional PCI and Disease.
His Coronary artery disease research includes themes of Predictive value of tests, Radiology, Functional testing, Ischemia and Revascularization. His study in Physical therapy is interdisciplinary in nature, drawing from both Psychosocial, Randomized controlled trial, Quality of life and Depression. His biological study spans a wide range of topics, including Framingham Risk Score, Diabetes mellitus, Meta-analysis, Electrocardiography and Survival analysis.
Ron T. van Domburg mainly focuses on Internal medicine, Cardiology, Physical therapy, Surgery and Percutaneous coronary intervention. The Cardiology study combines topics in areas such as Clinical endpoint, Logistic regression and Prospective cohort study. His Physical therapy study combines topics from a wide range of disciplines, such as Psychosocial, Randomized controlled trial, Psychological intervention and Quality of life.
His Surgery study frequently intersects with other fields, such as Cohort. His Percutaneous coronary intervention research integrates issues from Coronary artery disease and Confidence interval. The study incorporates disciplines such as Diabetes mellitus, Stent and Framingham Risk Score in addition to Myocardial infarction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
Joost Daemen;Peter Wenaweser;Keiichi Tsuchida;Linda Abrecht.
The Lancet (2007)
Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents
Andrew T.L. Ong;Eugène P. McFadden;Evelyn Regar;Peter P.T. de Jaegere.
Journal of the American College of Cardiology (2005)
Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World” The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry
Pedro A. Lemos;Patrick W. Serruys;Ron T. van Domburg;Francesco Saia.
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
Andrew T.L. Ong;Angela Hoye;Jiro Aoki;Carlos A.G. van Mieghem.
Journal of the American College of Cardiology (2005)
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.
Peter Wenaweser;Joost Daemen;Marcel Zwahlen;Ron van Domburg.
Journal of the American College of Cardiology (2008)
Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials
Jin M Cheng;Corstiaan A den Uil;Sanne E Hoeks;Martin van der Ent.
European Heart Journal (2009)
Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden
Georgios Sianos;Michail I. Papafaklis;Joost Daemen;Sofia Vaina.
Journal of the American College of Cardiology (2007)
Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease Insights From the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T-SEARCH)
Marco Valgimigli;Carlos A.G. van Mieghem;Andrew T.L. Ong;Jiro Aoki.
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study.
Pedro A. Lemos;Angela Hoye;Dick Goedhart;Chourmouzios A. Arampatzis.
Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002.
Angela Hoye;Ron T. van Domburg;Karel Sonnenschein;Patrick W. Serruys.
European Heart Journal (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: